ThursdayFeb 13, 2020 3:21 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Pursuing Untapped Chinese CBD Market

ChineseInvestors.com (OTCQB: CIIX), a financial news media and content platform that provides information to the global Chinese-speaking community, plans to expand its customer base with new hemp-based CBD products in 2020. Through CIIX’s CBD Biotech subsidiary, CEO Warren Wang plans to capitalize on the massive potential of the untapped Chinese CBD market. An article discussing the company reads, “Wang noted that China’s changing CBD laws can create volatility for CBD companies. However, those laws don’t apply to hemp-based CBD cosmetics, which are fully legal in China, Japan and the United States. Because CIIX is only involved in CBD cosmetics, the…

Continue Reading

ThursdayFeb 13, 2020 3:16 pm

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Targets Booming Hemp-Based CBD Products Market

Hemp biomass cultivation, extraction, formulation and refining entity HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) is slated for market growth through 2020 as the U.S. hemp-based, CBD-products market continues to flourish. A recent article discussing the company reads, “Overall, HTC Extraction Systems has a highly optimistic outlook when it comes to its extraction market expansion, where it is already a key player. The company expects a wealth of opportunities for growth in the near future, given the rapid expansion of the cannabinoid market as a whole. U.S. sales of hemp-based CBD products are projected to reach $22 billion by 2022,…

Continue Reading

ThursdayFeb 13, 2020 10:09 am

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH(TM)-Enabled CBD Infused Powders Available for Sale Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that its DehydraTECH(TM)-enabled CBD infused powders are now available for sale across the U.S. to businesses wanting to produce topicals and edibles with clinically proven performance for increased consumer satisfaction and improved stability. Consumers of both CBD/hemp and cannabis have recently become concerned about the potency and safety of the oil extract products they are purchasing. Lexaria's patented DehydraTECH(TM) technology and powder processing methodology, similar to a pasteurization technique in some ways, helps to not only preserve cannabinoid potency but also to reduce or eliminate…

Continue Reading

FridayFeb 07, 2020 3:00 pm

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Advances Strategic Expansion Plans

Plus Products (CSE: PLUS) (OTCQB: PLPRF), is a branded, cannabis-infused, products manufacturer of edibles created to support a healthy and active lifestyle. PLUS was recently featured in a NetworkNewsAudio interview (http://cnw.fm/r7amH). Blake Brennan, PLUS’s head of investor relations, noted in the interview that the company has the “no. 1 gummies brand here in California with the best-selling cannabis product across all categories.” An article further discussing the company’s offerings reads, “In the interview, Brennan explained key milestones that the company set out to achieve. ‘We wanted to build a brand and a product in the largest and most competitive market, make…

Continue Reading

ThursdayFeb 06, 2020 3:16 pm

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Leverages Social Media to Market, Sell New CBD Product

During a recently MoneyTV interview, ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang announced that the company will be launching a breakthrough CBD product in March. An article discussing the company reads, “One important aspect of the company’s strategy to increase profit is to sell its new CBD product through e-commerce using different social media platforms in 2020. Wang observed that multi-platform social media would play a key role in the company’s marketing to a younger consumer audience of its CBD line. He specifically mentioned using platforms such as TikTok in the campaign, which launched in 2017 and accrued 500 million users…

Continue Reading

ThursdayFeb 06, 2020 3:09 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Providing Alternative to Inhalation via Patented Oral Drug-Delivery Technology

British Columbia-based, biodelivery technology developer Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is committed to the idea that better alternative methods for drug delivery exist than inhalation. A recent article discussing the company reads, “Swallowed medications have historically been slower to provide effective action than inhaled ones, leading substance users looking for a quick fix to lean toward the latter. But the deleterious and deadly consequences of smoking tobacco products have been publicly acknowledged for decades, though hardly stemming the tide of nicotine addiction as one generation succeeds another. . . . The continued preference for the rapid delivery of inhaled…

Continue Reading

WednesdayFeb 05, 2020 12:32 pm

CBDNewsBreaks – Neutra Corp. (NTRR) Secures New Round of Private Equity to Drive Vertical Integration

Neutra Corp. (OTC: NTRR) on Tuesday announced its January 1, 2020 receipt of a new round of private equity that it intends to use in its ongoing campaign to become a vertically integrated producer, manufacturer and distributor of hemp-based CBD health products. “This is a welcome event that strengthens our company and puts it in a better long-term position to compete and succeed in the marketplace,” Neutra CEO Sydney Jim said in the news release. “This funding round gives us the ability to pursue our strategies and goals, as well as potentially expand our vision for the future. We had…

Continue Reading

TuesdayFeb 04, 2020 11:59 am

CBDNewsBreaks – No Borders, Inc. (NBDR) Files First Blockchain Provisional Patent for its CBD LabChain Platform

No Borders (OTC: NBDR) today announced that it has successfully filed the first blockchain provisional patent for its CBD LabChain platform. According to the update, the provisional patent, registered as Application Serial #62969531 with the USPTO on Feb. 3, 2020, now allows NBDR’s CBD LabChain platform to operate with “Patent Pending” identifiers and messaging. This marks the very first Patent Pending achievement for the No Borders family of companies and supports the company’s mission to impact shareholder value by building a valuable portfolio of IP assets. “It has been a long road to get to this day and I am…

Continue Reading

FridayJan 31, 2020 2:23 pm

CBDNewsBreaks – No Borders Inc. (NBDR) Leverages Blockchain Technology to Provide Security to Cannabis Industry

No Borders (OTC: NBDR) has developed a blockchain data-security platform called CBD Lab Chain that utilizes Ethereum blockchain technology to deliver supply-chain transparency. An article discussing the company reads, “No Borders is a multifaceted brand-development and marketing business using its new blockchain-technology platform, CBD LabChain, to protect consumers and securely inform them of the supply-chain safety of cannabidiol (‘CBD’) products, which are potentially susceptible to chemical taints, inordinate tetrahydrocannabinol (THC) drug levels and incorrect CBD quality claims. The technology is currently used to safeguard CBD products developed by another subsidiary, No Borders Naturals, but has since become a potential revenue…

Continue Reading

FridayJan 31, 2020 9:56 am

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Discusses Impressions over the Coronavirus on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives that offer insights into various companies and their operations and future outlooks. This week’s program featured CIIX CEO Warren Wang as he discussed his impressions over the Coronavirus. “I’m not a doctor; I cannot say that CBD can help your immune system,” Wang stated in the interview, indicating that, based on his experience and other sources such as YouTube, he…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000